{"id":101194,"date":"2009-12-25T17:30:04","date_gmt":"2009-12-25T22:30:04","guid":{"rendered":"http:\/\/www.businessinsider.com\/the-five-sloppiest-drug-companies-of-2009-2009-12"},"modified":"2009-12-25T17:30:04","modified_gmt":"2009-12-25T22:30:04","slug":"the-sloppiest-drug-companies-of-2009-genz","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/101194","title":{"rendered":"The Sloppiest Drug Companies of 2009  (GENZ)"},"content":{"rendered":"<p><img decoding=\"async\" class=\"float_right\" src=\"http:\/\/static.businessinsider.com\/~~\/f?id=4b353ae900000000002fe0b1&amp;maxX=400\" border=\"0\" alt=\"Broken Vial\" width=\"400\" \/><\/p>\n<p>As healthcare reform hits a historical turning point (for better or worse), Jim Edwards at BNET Pharma reminisces about some of the most screwed up drug companies&#8217; in 2009.<\/p>\n<p>They&#8217;re a nice reminder of how dangerous investing in drug companies can be. You really never know what kind of huge, random disaster is going to pop up.<\/p>\n<p>Such as this:<\/p>\n<p style=\"padding-left: 30px;\"><a href=\"http:\/\/industry.bnet.com\/pharma\/10005892\/the-5-worst-drug-companies-of-2009\/?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+bnet%2Fpharma+%28BNET+Industries+-+Pharma+Insights%29&amp;utm_content=Google+Reader\">BNET Pharma:<\/a> <strong><\/strong><\/p>\n<p style=\"padding-left: 30px;\"><strong>Genzyme (GENZ)<\/strong> <strong>&#8211;<\/strong> Your company holds a monopoly on a drug for Gaucher&rsquo;s disease. It&rsquo;s a license to print money. How do you screw this up? Do what what Genzyme did: <strong>Introduce a bunch of garbage &mdash; literally bits of rubber and metal &mdash; into your drugs. Have this come after one of your sites was infected with a virus.<\/strong> Get two new drugs rejected by the FDA and have a third one dropped during R&amp;D. Meanwhile, make sure your CEO spends the year enriching himself with a $10 million stock sale on top of $50 million in compensation over the previous three years. That&rsquo;s why Genzyme ended the year with Genzyme&rsquo;s founder calling for CEO Henri Termeer to resign.<\/p>\n<p style=\"padding-left: 30px;\"><a href=\"http:\/\/industry.bnet.com\/pharma\/10005892\/the-5-worst-drug-companies-of-2009\/?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+bnet%2Fpharma+%28BNET+Industries+-+Pharma+Insights%29&amp;utm_content=Google+Reader\">Continue reading the five worst drug companies at BNET Pharma &gt;&gt;<\/a><\/p>\n<p><a href=\"http:\/\/www.businessinsider.com\/the-five-sloppiest-drug-companies-of-2009-2009-12#comments\">Join the conversation about this story &#187;<\/a><\/p>\n<p><b>See Also:<\/b><\/p>\n<ul>\n<li><a href=\"http:\/\/www.businessinsider.com\/drug-prices-dont-fall-because-medicare-isnt-allowed-to-bargain-2009-12\">Drug Prices Don&#8217;t Fall Because Medicare Isn&#8217;t Allowed To Bargain<\/a><\/li>\n<li><a href=\"http:\/\/www.businessinsider.com\/drug-advertising-is-completely-broken-2009-11\">Drug Advertising Is Completely Broken<\/a><\/li>\n<li><a href=\"http:\/\/www.businessinsider.com\/pharma-exec-convicted-of-pushing-alternative-uses-for-drug-2009-9\">Pharma Exec Convicted Of Pushing Alternative Uses For Drug<\/a><\/li>\n<\/ul>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/TheMoneyGame\/~4\/Z7DwU2yjjZk\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>As healthcare reform hits a historical turning point (for better or worse), Jim Edwards at BNET Pharma reminisces about some of the most screwed up drug companies&#8217; in 2009. They&#8217;re a nice reminder of how dangerous investing in drug companies can be. You really never know what kind of huge, random disaster is going to [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-101194","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/101194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=101194"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/101194\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=101194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=101194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=101194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}